Details for New Drug Application (NDA): 050560
✉ Email this page to a colleague
NDA 050560 describes CEFIZOX, which is a drug marketed by Astellas and is included in three NDAs. Additional details are available on the CEFIZOX profile page.
The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
The generic ingredient in CEFIZOX is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
Summary for 050560
| Tradename: | CEFIZOX |
| Applicant: | Astellas |
| Ingredient: | ceftizoxime sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050560
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Sep 15, 1983 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Sep 15, 1983 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Sep 15, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
